Lantheus Holdings, Inc. (NASDAQ: LNTH) is a Healthcare company (Drug Manufacturers - Specialty & Generic) with a market capitalization of $6.7B. The Maz Rating grades it against the other companies in its sector.
Lantheus Holdings, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $101.80, Lantheus Holdings, Inc. trades at 24.6x trailing earnings, 4.3x sales and 4.9x book value, with an EV/EBITDA of 13.3. Over the last twelve months it generated about $1.6B of revenue and $271M of net income. It runs a gross margin of 61.3%, an operating margin of 18.6% and a net margin of 17.3%. It shows return on equity of 21.7%, return on invested capital of 10.9% and a free cash flow yield of 5.9%. On the balance sheet: a debt-to-equity ratio of 0.04 and a current ratio of 3.25. Over the past 52 weeks the share price ranged from $51.84 to $111.86, with a beta of -0.06.
Lantheus Holdings, Inc. does not currently pay a dividend.
19 Wall Street analyst ratings cover the stock: 10 Buy and 9 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.